Diabetic macular edema diagnosis and treatment in the real world: an analysis of Medicare claims data (2008 to 2010)
PU Dugel, A Layton, R Varma - Ophthalmic Surgery, Lasers and …, 2016 - journals.healio.com
BACKGROUND AND OBJECTIVE: To characterize vascular endothelial growth factor
(VEGF) inhibitor treatment patterns in patients with diabetic macular edema (DME) using a …
(VEGF) inhibitor treatment patterns in patients with diabetic macular edema (DME) using a …
Diabetic Macular Edema Diagnosis and Treatment in the Real World: An Analysis of Medicare Claims Data (2008 to 2010)
PU Dugel, A Layton, R Varma - Ophthalmic Surgery, Lasers & …, 2016 - search.proquest.com
To characterize vascular endothelial growth factor (VEGF) inhibitor treatment patterns in
patients with diabetic macular edema (DME) using a Medicare Standard Analytic Files Part …
patients with diabetic macular edema (DME) using a Medicare Standard Analytic Files Part …
Diabetic Macular Edema Diagnosis and Treatment in the Real World: An Analysis of Medicare Claims Data (2008 to 2010).
PU Dugel, A Layton, RB Varma - Ophthalmic Surgery, Lasers & …, 2016 - europepmc.org
Results The average number of anti-VEGF injection claims for DME per patient rose from 3.1
to 4.6 per year (mean: 4.2). Within 1 year of diagnosis, 46% of patients received their final …
to 4.6 per year (mean: 4.2). Within 1 year of diagnosis, 46% of patients received their final …
Diabetic Macular Edema Diagnosis and Treatment in the Real World: An Analysis of Medicare Claims Data (2008 to 2010)
PU Dugel, A Layton, RB Varma - 2016 - hero.epa.gov
BACKGROUND AND OBJECTIVE: To characterize vascular endothelial growth factor
(VEGF) inhibitor treatment patterns in patients with diabetic macular edema (DME) using a …
(VEGF) inhibitor treatment patterns in patients with diabetic macular edema (DME) using a …
Diabetic Macular Edema Diagnosis and Treatment in the Real World: An Analysis of Medicare Claims Data (2008 to 2010)
PU Dugel, A Layton, RB Varma - … surgery, lasers & …, 2016 - pubmed.ncbi.nlm.nih.gov
Background and objective To characterize vascular endothelial growth factor (VEGF)
inhibitor treatment patterns in patients with diabetic macular edema (DME) using a Medicare …
inhibitor treatment patterns in patients with diabetic macular edema (DME) using a Medicare …
Diabetic Macular Edema Diagnosis and Treatment in the Real World: An Analysis of Medicare Claims Data (2008 to 2010)
PU Dugel, A Layton, R Varma - Ophthalmic Surgery, Lasers and Imaging …, 2016 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> BACKGROUND AND OBJECTIVE:</jats: title>< jats: p> To
characterize vascular endothelial growth factor (VEGF) inhibitor treatment patterns in …
characterize vascular endothelial growth factor (VEGF) inhibitor treatment patterns in …